Paper486222
In vitro hexosamine depletion of intact articular cartilage by E-prostaglandins: prevention by chloroquine.
Fulkerson JP and 2 others. Arthritis Rheum, 1979. Cited by 37 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vitro hexosamine depletion of intact articular cartilage by E-prostaglandins: prevention by chloroquine. Papers, record 486222. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/486222
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro hexosamine depletion of intact articular cartilage by E-prostaglandins: prevention by chloroquine.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cartilage, Articular | Major topic |
| Chloroquine | Major topic |
| Hexosamines | Major topic |
| Peptide Hydrolases | Major topic |
| Prostaglandins E, Synthetic | Major topic |
| Animals | |
| Dogs | |
| In Vitro Techniques | |
| Knee Joint | |
| RNA | |
| Time Factors |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32715647 | Hydroxychloroquine in rheumatic autoimmune disorders and beyond. | EMBO Mol Med | 2020 | https://conductscience.org/library/papers/32715647 | PubMed |
| 26246395 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. | Inflammopharmacology | 2015 | https://conductscience.org/library/papers/26246395 | PubMed |
| 7724995 | Influence of interleukin-1 beta, tumour necrosis factor alpha and prostaglandin E2 on chondrogenesis and cartilage matrix breakdown in vitro. | Rheumatol Int | 1995 | https://conductscience.org/library/papers/7724995 | PubMed |
| 7159397 | Adenylate cyclase of human articular chondrocytes. Responsiveness to prostaglandins and other hormones. | Biochem J | 1982 | https://conductscience.org/library/papers/7159397 | PubMed |
| 6287562 | Lysosomal elastase: effect on mechanical and biochemical properties of normal cartilage, inhibition by polysulfonated glycosaminoglycan, and binding to chondrocytes. | Rheumatol Int | 1981 | https://conductscience.org/library/papers/6287562 | PubMed |
| 3472453 | Differences in prostanoid production between healthy and rheumatic synovia in vitro. | Agents Actions | 1987 | https://conductscience.org/library/papers/3472453 | PubMed |
| 2786669 | Effects of diclofenac, indomethacin, tolfenamic acid and hydrocortisone on prostanoid production in healthy and rheumatic synovial cells. | Agents Actions | 1989 | https://conductscience.org/library/papers/2786669 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/486222
GET https://conductscience.org/api/papers/v1/486222/authors